SARS-CoV-2/grip A /grip B
Non pwodwi
Twous Deteksyon Konbine Asid Nikleyik HWTS-RT148-SARS-CoV-2/grip A/grip B (PCR Fliyoresans)
Chanèl
| Non Chanèl | PCR-Melanj 1 | PCR-Melanj 2 |
| Chanèl FAM | Jèn ORF1ab la | TVA |
| Chanèl VIC/HEX | Kontwòl entèn | Kontwòl entèn |
| Chanèl CY5 | Jèn N | / |
| Chanèl ROX | Jèn E | IVB |
Paramèt teknik
| Depo | -18℃ |
| Dire lavi etajè | 12 mwa |
| Kalite echantiyon | prelèvman nazofarinjèn ak prelèvman orofarinjèn |
| Sib | Twa sib pou SARS-CoV-2 (jèn Orf1ab, N ak E)/grip A /grip B |
| Ct | ≤38 |
| CV | ≤10.0% |
| LoD | SARS-CoV-2：300 Kopi/mL viris grip A: 500 kopi/mL viris grip B: 500 kopi/mL |
| Espesifikite | a) Rezilta tès kwaze yo te montre ke twous la te konpatib ak kowonaviris imen SARSr-CoV, MERSr-CoV, HcoV-OC43, HcoV-229E, HcoV-HKU1, HCoV-NL63, viris respiratwa senkityal A ak B, viris parainfluenza 1, 2 ak 3, rinovirus A, B ak C, adenovirus 1, 2, 3, 4, 5, 7 ak 55, metapneumovirus imen, enterovirus A, B, C ak D, viris sitoplasmik poumon imen, viris EB, viris lawoujòl Sitomegalovirus imen, rotavirus, norovirus, viris oreyon, viris varisèl zoster, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella, pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Mycobacterium tuberculosis, Aspergillus fumigatus, Candida albicans, Candida glabrata Pa te gen okenn reyaksyon kwaze ant Pneumocystis yersini ak Cryptococcus neoformans. b) Kapasite anti-entèferans: chwazi mucin (60mg/mL), 10% (V/V) san imen, difenilefrin (2mg/mL), idroksimetilzolin (2mg/mL), klori sodyòm (ki gen prezèvatif) (20mg/mL), beclomethasone (20mg/mL), dexamethasone (20mg/mL), flunisone (20μg/mL), triamcinolone acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), α-Interferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), pramivir (1mg/mL), lopinavir (500mg/mL), ritonavir (60mg/mL), mupirocin (20mg/mL), azitromisin (1mg/mL), ceprotene (40μg/mL) Meropenem (200mg/mL), levofloxacin (10μg/mL) ak tobramycin (0.6mg/mL). Rezilta yo te montre ke sibstans entèferans yo nan konsantrasyon ki anwo yo pa t gen okenn repons entèferans ak rezilta deteksyon patojèn yo. |
| Enstriman Aplikab yo | Sistèm PCR an tan reyèl Applied Biosystems 7500 yo Sistèm PCR rapid an tan reyèl Applied Biosystems 7500 SLAN ®-96P Sistèm PCR an tan reyèl Sistèm PCR an tan reyèl QuantStudio™ 5 Siklis Limyè®480 Sistèm PCR an tan reyèl Sistèm Deteksyon PCR an Tan Reyèl LineGene 9600 Plus MA-6000 Siklis tèmik kantitatif an tan reyèl Sistèm PCR an tan reyèl BioRad CFX96 la Sistèm PCR an tan reyèl BioRad CFX Opus 96 |
Solisyon PCR total
